Cargando…
Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils
Myeloid cells co-expressing the markers CD11b, Ly-6G, and SiglecF can be found in large numbers in murine lung adenocarcinomas and accelerate cancer growth by fostering tumor cell invasion, angiogenesis, and immunosuppression; however, some of these cells’ fundamental features remain unexplored. Her...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508173/ https://www.ncbi.nlm.nih.gov/pubmed/32966785 http://dx.doi.org/10.1016/j.celrep.2020.108164 |
_version_ | 1783585379220193280 |
---|---|
author | Pfirschke, Christina Engblom, Camilla Gungabeesoon, Jeremy Lin, Yunkang Rickelt, Steffen Zilionis, Rapolas Messemaker, Marius Siwicki, Marie Gerhard, Genevieve M. Kohl, Anna Meylan, Etienne Weissleder, Ralph Klein, Allon M. Pittet, Mikael J. |
author_facet | Pfirschke, Christina Engblom, Camilla Gungabeesoon, Jeremy Lin, Yunkang Rickelt, Steffen Zilionis, Rapolas Messemaker, Marius Siwicki, Marie Gerhard, Genevieve M. Kohl, Anna Meylan, Etienne Weissleder, Ralph Klein, Allon M. Pittet, Mikael J. |
author_sort | Pfirschke, Christina |
collection | PubMed |
description | Myeloid cells co-expressing the markers CD11b, Ly-6G, and SiglecF can be found in large numbers in murine lung adenocarcinomas and accelerate cancer growth by fostering tumor cell invasion, angiogenesis, and immunosuppression; however, some of these cells’ fundamental features remain unexplored. Here, we show that tumor-infiltrating CD11b(+) Ly-6G(+) SiglecF(high) cells are bona fide mature neutrophils and therefore differ from other myeloid cells, including SiglecF(high) eosinophils, SiglecF(high) macrophages, and CD11b(+) Ly-6G(+) myeloid-derived suppressor cells. We further show that SiglecF(high) neutrophils gradually accumulate in growing tumors, where they can live for several days; this lifespan is in marked contrast to that of their SiglecF(low) counterparts and neutrophils in general, which live for several hours only. Together, these findings reveal distinct attributes for tumor-promoting SiglecF(high) neutrophils and help explain their deleterious accumulation in the tumor bed. |
format | Online Article Text |
id | pubmed-7508173 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | The Authors. |
record_format | MEDLINE/PubMed |
spelling | pubmed-75081732020-09-23 Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils Pfirschke, Christina Engblom, Camilla Gungabeesoon, Jeremy Lin, Yunkang Rickelt, Steffen Zilionis, Rapolas Messemaker, Marius Siwicki, Marie Gerhard, Genevieve M. Kohl, Anna Meylan, Etienne Weissleder, Ralph Klein, Allon M. Pittet, Mikael J. Cell Rep Report Myeloid cells co-expressing the markers CD11b, Ly-6G, and SiglecF can be found in large numbers in murine lung adenocarcinomas and accelerate cancer growth by fostering tumor cell invasion, angiogenesis, and immunosuppression; however, some of these cells’ fundamental features remain unexplored. Here, we show that tumor-infiltrating CD11b(+) Ly-6G(+) SiglecF(high) cells are bona fide mature neutrophils and therefore differ from other myeloid cells, including SiglecF(high) eosinophils, SiglecF(high) macrophages, and CD11b(+) Ly-6G(+) myeloid-derived suppressor cells. We further show that SiglecF(high) neutrophils gradually accumulate in growing tumors, where they can live for several days; this lifespan is in marked contrast to that of their SiglecF(low) counterparts and neutrophils in general, which live for several hours only. Together, these findings reveal distinct attributes for tumor-promoting SiglecF(high) neutrophils and help explain their deleterious accumulation in the tumor bed. The Authors. 2020-09-22 2020-09-22 /pmc/articles/PMC7508173/ /pubmed/32966785 http://dx.doi.org/10.1016/j.celrep.2020.108164 Text en © 2020 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Report Pfirschke, Christina Engblom, Camilla Gungabeesoon, Jeremy Lin, Yunkang Rickelt, Steffen Zilionis, Rapolas Messemaker, Marius Siwicki, Marie Gerhard, Genevieve M. Kohl, Anna Meylan, Etienne Weissleder, Ralph Klein, Allon M. Pittet, Mikael J. Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils |
title | Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils |
title_full | Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils |
title_fullStr | Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils |
title_full_unstemmed | Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils |
title_short | Tumor-Promoting Ly-6G(+) SiglecF(high) Cells Are Mature and Long-Lived Neutrophils |
title_sort | tumor-promoting ly-6g(+) siglecf(high) cells are mature and long-lived neutrophils |
topic | Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7508173/ https://www.ncbi.nlm.nih.gov/pubmed/32966785 http://dx.doi.org/10.1016/j.celrep.2020.108164 |
work_keys_str_mv | AT pfirschkechristina tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT engblomcamilla tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT gungabeesoonjeremy tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT linyunkang tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT rickeltsteffen tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT zilionisrapolas tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT messemakermarius tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT siwickimarie tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT gerhardgenevievem tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT kohlanna tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT meylanetienne tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT weisslederralph tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT kleinallonm tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils AT pittetmikaelj tumorpromotingly6gsiglecfhighcellsarematureandlonglivedneutrophils |